Condition
Primary Early-stage Non-small Cell Lung Cancer
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Early P 1 (1)
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
NCT07498439Early Phase 1Not Yet RecruitingPrimary
TILs Therapy for Multiple Primary Early-Stage NSCLC
Showing all 1 trials